Copy
View this email in your browser
Stop TB Partnership Newsletter - June 2015
High Level Dialogue New Funding Model Panel

India accelerates the detection and enrolment on treatment for MDR-TB & TB/HIV infected people to save lives 

Expanding access to drug-resistant TB services in India


India, the second highest populous country in the world -- accounts for the highest share of TB incidence cases globally. Among its 1.2 billion population, 2.1 million TB cases are estimated to occur annually. This translates to a quarter of the global TB incidence. In order to effectively address this challenge, the country implemented the Revised National TB Control Programme (RNTCP) in 1997 achieving complete national coverage in the year 2006. The RNTCP detects and treats approximately 1.5 million cases annually. TB elimination is however not achievable unless drug-resistant TB -- the most critical challenge in recent times -- is not effectively addressed. Diagnosis and the management of drug-resistant TB poses greater challenges due to the complexity of diagnosis, its long duration in treatment and the potentially toxic drugs. Additionally the high cost in resources, the transformation of clinical management into public health management settings, and the need for specialists' support for management make it even more challenging. Full story here as submitted by the Revised National TB Control Programme, India. 

Joint TB/HIV collaboration in India saves countless lives 

*Meena visited the government hospital in the East Godavari district of Andhra  Pradesh with cough and fever symptoms. Her sputum test revealed that she had TB. She was put on DOTS (anti-TB treatment). She was additionally counselled to get an HIV test done, which is a standard for TB care in India. Meena, however, chose not to get tested for HIV. When the TB health visitor made a home visit, he found that her HIV status was not known and she was once again advised to get the test done. She still did not comply. Under the TB/HIV Collaboration Framework, a line list of patients is shared. This list showed that Meena was recommended an HIV test, but had missed it. She was once again counselled and motivated to undergo the test. Finally, due to persistent efforts of healthcare providers, she got herself tested for the HIV virus. Her test results turned out to be HIV positive. Full story here as submitted by the Revised National TB Control Programme, India. 

High Level Dialogue New Funding Model Panel
The second Global Plan to Stop TB 2016-2020 regional consultation in Bangkok, Thailand.
 

Global Plan to Stop TB 2016-2020: Second regional consultation in Bangkok -- innovate in engaging communities and private sector to achieve the 90-(90)-90 targets

The second of four regional consultations on the Global Plan to Stop TB 2016-2020 reinforced the importance for a paradigm-shift in the way TB is fought in countries, underlying the importance of engaging the private sector, the need for community-led demand and for innovations in care delivery. Full story here.

High Level Dialogue New Funding Model Panel
 

A reason for investment in TB REACH: TB detection among kids improved 33% in Nepal

Since 2013, the Stop TB Partnership's TB REACH Wave 3 programme has been engaged in intensified early TB case detection amongst children aged 0-14 years in low case-finding districts through the involvement of volunteers and community members. The project was implemented by a non-governmental organization working in partnership with the National TB Programme in 10 districts with various intensified case-finding strategies. 

This is the first study in Nepal to assess the impact of intensified case-finding strategies in improving the case detection and diagnosis of childhood TB. The findings are encouraging: there was a significant increase in absolute numbers of TB case detection, particularly apparent in young children aged 0-4 years and in children with smear-negative PTB and EPTB. To read the full study, click here.  

High Level Dialogue New Funding Model Panel
The race for faster TB tests: as drug-resistant strains of TB develop, researchers strive to detect it sooner. Photo: WSJ/Texas A&M Health Science
 

In the media: TB, global health & development news

High Level Dialogue New Funding Model Panel
 

News from our partners

Share
Tweet
Forward
Upcoming Stop TB Partnership Meetings

3rd Regional Consultation for the Global Plan to Stop TB 2016-2020
23-24 July
Istanbul, Turkey

Stop TB Partnership in collaboration with the Global Fund & International HIV/AIDS Alliance:
Workshop to Strengthen TB Constituencies in Country Coordinating Mechanisms
28-30 July
Kuala Lumpur, Malaysia

Global Fund Board Retreat
29-30 July

Geneva, Switzerland
LIVE NOW: Virtual consultation for the Global Plan to Stop TB 2016-2020
 
The development of the new Global Plan to Stop TB 2016-2020 seeks to be as inclusive as possible and the online consultation aims to reflect a diverse range of input in the Plan update, including the voices of people and professional groups and TB constituencies who may not have been reached previously. 

Participants are encouraged to provide comments -- based on the top line questions asked -- on the introduction and seven main chapters that make up the Plan. The online consultation will run until 10 August 2015. We look forward to hearing from you. 
Top News Stories

Announcements

New Global Drug Facility Communications Listserv

The Stop TB Partnership's Global Drug Facility now has a special communications channel dedicated to Procurement & Supply Management issues. Subscribe to all these alerts by clicking here
Multimedia Spotlight
 
Featured Peer-Reviewed Papers
 


Revitalizing Our
Online Presence

The Stop TB Partnership is revamping its website. In a few days, we will unveil it! Watch this space for more. 
Event Schedule

BRICS Heads of State Summit
8 - 9 July
Ufa, Russia

3rd International Conference on Financing for Development
13 - 16 July
Addis Ababa, Ethiopia

RESULTS International Conference
18 - 21 July
Washington D.C., USA

 
Copyright ©2015 Stop TB Partnership, All rights reserved.
You are receiving this email because you are signed up to the Stop TB Communications Listserv. 

Our mailing address is:
Stop TB Partnership Secretariat
United Nations Office for Project Services
Chemin de Blandonnet 2
CH-1214 Vernier
Geneva, Switzerland


Unsubscribe from this list